Showing 921 - 940 results of 66,559 for search '(( 50 ((we decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 2 d decrease ))', query time: 1.41s Refine Results
  1. 921

    AQP1 abundance. by Sophie Constantin Lütken (689916)

    Published 2015
    “…Immunoblot was reacted with anti-AQP1 antibody and reveals 29 kDa and 35–50 kDa AQP1-bands (<i>A-E</i>). Data are presented in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0116501#pone.0116501.t009" target="_blank">Table 9</a>. …”
  2. 922
  3. 923
  4. 924

    Shortening of mTL anticipates accumulation of DDR markers, decrease in cell proliferation and increase in apoptotis with age. by Madalena C. Carneiro (102302)

    Published 2016
    “…<p>A-D) Representative immunofluorescence images of DNA damage (γH2AX), proliferation (PCNA) and apoptosis (TUNEL) for gut (A—dashed outline identifies the villi), kidney marrow (B), testis (C) and muscle (D—dashed outline identifies the fibers) of WT (at 3, 12 and 36 months) and <i>tert</i><sup><i>-/-</i></sup> mutant siblings (at 3 and 12 months). …”
  5. 925
  6. 926
  7. 927

    S1 File - by Chantelle M. de Vet (16535257)

    Published 2024
    “…<div><p>Objectives</p><p>Two-dimensional speckle tracking (2D-STE) strain analysis holds promise for assessing fetal cardiac function. …”
  8. 928
  9. 929
  10. 930
  11. 931
  12. 932
  13. 933

    Substitution of a lysine residue at position 8 of two model 9mer H2-K<sup>b</sup> epitope precursors leads to a marked decrease of N-terminus trimming by ERAP1 <i>in vitro</i>. by Irini Evnouchidou (375919)

    Published 2013
    “…<p><i>Panels </i><i>A</i><i> and </i><i>B</i>, peptides LSIINFEKL and the variant LSIINFEAL (both at 50 µM) were incubated with 7.8 nM of ERAP1 for 1 hr at 37°C and the products analyzed by RP-HPLC. …”
  14. 934

    Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

    Published 2016
    “…Although many promising chemotherapeutics have been developed upon the basis of polyaromatic DNA intercalating systems, these candidates did not proceed past clinical trials on account of their dose-limiting toxicity. Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. …”
  15. 935

    Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

    Published 2016
    “…Although many promising chemotherapeutics have been developed upon the basis of polyaromatic DNA intercalating systems, these candidates did not proceed past clinical trials on account of their dose-limiting toxicity. Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. …”
  16. 936

    Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

    Published 2016
    “…Although many promising chemotherapeutics have been developed upon the basis of polyaromatic DNA intercalating systems, these candidates did not proceed past clinical trials on account of their dose-limiting toxicity. Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. …”
  17. 937

    Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

    Published 2016
    “…Although many promising chemotherapeutics have been developed upon the basis of polyaromatic DNA intercalating systems, these candidates did not proceed past clinical trials on account of their dose-limiting toxicity. Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. …”
  18. 938

    Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

    Published 2016
    “…Although many promising chemotherapeutics have been developed upon the basis of polyaromatic DNA intercalating systems, these candidates did not proceed past clinical trials on account of their dose-limiting toxicity. Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. …”
  19. 939
  20. 940